| 11341/13381 | US=55 / Biol/Mol Avramis VI. NONMEM population models of cytosine arabinoside and fludarabine phosphate in pediatric patients with leukemia. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 331-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. NONMEM; CITOSINA DE ARABINOSIDE; FOSFATO DE FLUDARABINA; PACIENTES PEDIATRICOS; LEUCEMIA; LEUCEMIA LINFOBLASTICA AGUDA; VOLUME DE DISTRIBUICAO |
| 11342/13381 | US=55 / Biol/Mol Meier C, Balzarini J, Meerbach A. The cycloSal-nucleotide delivery system: development of chemical trojan horses as antiviral agents. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 353-401. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. SISTEMA DE ENTREGA; CICLOSAL DE NUCLEOTIDEO; AGENTES ANTIVIRAIS |
| 11343/13381 | US=55 / Biol/Mol Gojkovic Z, Karlsson A. Purine and pyrimidine-based analogs and suicide gene therapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 403-39. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. PURINA; ANALOGOS DE PIRIMIDINA-BASE; TERAPIA DE GENE SUICIDA; ACICLOVIR; CITOSINA DESAMINASE; DESOXINUCLEOSIDO QUINASE; SISTEMA DE ENTREGA DE DROGA; FLUOROCITOSINE; GANCICLOVIR; TERAPIA GENICA; TIMIDINA QUINASE DO HERPES; GENES SUICIDAS; TIMIDINA QUINASE |
| 11344/13381 | US=55 / Biol/Mol Direcks WGE, Lammertsma AA, Molthoff CFM. 3-deoxy-3-fluorothymidine as a tracer of proliferation in positron emission tomographyPurine and pyrimidine-based analogs and suicide gene therapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 441-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. 3-DESOXI-3-FLUOROTIMIDINA; MARCADOR DE PROLIFERACAO; TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 11345/13381 | US=59 / Enfermagem Milone-Nuzzo P, McCorkle R. End-of-life care across settings: home care. In: Ferrell BR, Coyle N. Textbook of palliative nursing. Oxford: University Press, 2006. p. 771-85. ISBN 978-0-19-51549-3. ATENDIMENTO DOMICILIAR; CUIDADOS DE ENFERMAGEM EM CASA; ATENDIMENTO DOMICILIAR. PACIENTES TERMINAIS; QUALIDADE DE UM ATENDIMENTO; HISTORIA HOME CARE; PACIENTES COM CANCER. CUIDADOS; PROGRAMAS DE CUIDADOS PALIATIVOS EM CASA |
| 11346/13381 | US=59 / Enfermagem Sun V. End-of-life care across settings: palliative chemotherapy and clinical trials in advanced cancer: the nurse's role. In: Ferrell BR, Coyle N. Textbook of palliative nursing. Oxford: University Press, 2006. p. 881-92. ISBN 978-0-19-51549-3. QUIMIOTERAPIA PALIATIVA; ENSAIOS CLINICOS EM CANCER AVANCADO; PAPEL DO ENFERMEIRO; PACIENTES COM CANCER AVANCADO; QUALIDADE DE VIDA; QUIMIOTERAPIA PALIATIVA; INTENCAO DE TRATAMENTO |
| 11347/13381 | US=59 / Enfermagem Goldstein ML, Byrnes-Casey M, Collins JJ. Pediatric palliative care: pediatric pain: knowing the child before you. In: Ferrell BR, Coyle N. Textbook of palliative nursing. Oxford: University Press, 2006. p. 991-1008. ISBN 978-0-19-51549-3. PEDIATRICA. CUIDADOS PALIATIVOS; DOR PEDIATRICA; DOR NEUROPATICA; QUEIMADURAS; CANCER; INFECCAO POR VIRUS DA IMUNODEFICIENCIA HUMANA; DOENCA DAS CELULAS SICKEL; ARTRITE CRONICA JUVENIL; FIBROSE CISTICA |
| 11348/13381 | Câncer Pellizzon ACA. Reducing normal tissue complications in radiotherapy and neoadjuvant chemoradiotherapy for rectal cancer (Editorial). Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 59, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.59.pdf |
| 11349/13381 | Câncer Ramos AP, Marques GIG, Mendonça YA, Dourado JC, Soares RBA. Clinical evaluation of normal tissue toxicity induced by ionizing radiation in cases of laryngeal carcinoma. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 60-3, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.60-3.pdf EFEITOS ADVERSOS; CANCER DE LARINGE; TOXICIDADE; RADIOTERAPIA |
| 11350/13381 | Câncer Santos LG, Lages RB, Alves GCM, Araújo JKL. Assessment of tumor regression in patients with rectal carcinoma treated with neoadjuvant chemoradiotherapy. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 64-9, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.64-9.pdf QUIMIOPREVENCAO; CANCER COLORETAL; ONCOLOGIA; TERAPIA NEOADJUVANTE; CANCER DE RETO |
| 11351/13381 | Câncer Pinto VMC, Kato GF, Lopes RN, Alves FA. Jaw osteonecrosis in patients receiving bisphosphonate therapy: results from a single institution. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 70-5, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.70-5.pdf BIFOSFONATO; OSTEORADIONECROSE DE MANDIBULA; OSTEORADIONECROSE |
| 11352/13381 | US=61 / Câncer Dewhirst MW, Cao Y, Moeller B, Li CY. Physiological resistance: the cycle between angiogenesis perfusion, and hypoxia in tumors. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 1-19. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 11353/13381 | US=61 / Câncer Song CW, Griffin R, Park HJ. Physiological resistance: influence of tumor pH on therapeutic response. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 21-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. INTRATUMOR PH; PH EXTRACELULAR; PH INTRACELULAR; INTRATUMORAL MECANISMO DE CONTROLO DE PH; QUIMIOTERAPIA; RADIOTERAPIA; HIPERTERMIA |
| 11354/13381 | US=61 / Câncer Lunt SJ, Hill RP. Physiological resistance: tumor oxygenation and treatment response. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 43-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. HIPOXIA TUMOR; HIF-1; MARCADORES DE HIPOXIA; DROGAS BIORREDUTIVA; DIRIGIDO GENE-ENZIMA PRO-DROGA TERAPEUTICA |
| 11355/13381 | US=61 / Câncer Rak JW, Coomber B, Yu JL. Physiological resistance: oncogenes and tumor suppressor genes in therapeutic resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 67-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ONCOGENES; GENES SUPRESSORES DE TUMORES; RESISTENCIA AS DROGAS; MICROAMBIENTE; INTERACOES TUMOR-HOSPEDEIRO |
| 11356/13381 | US=61 / Câncer Mankoff DA, Krohn KA. Physiological resistance: PET imaging of response and resistance to cancer therapy. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 105-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CANCER DE IMAGENS; PET; RESPOSTA; RESISTENCIA; IMAGIOLOGIA MOLECULAR |
| 11357/13381 | US=61 / Câncer Mantle I, Dontu G, Liu S, Wicha MS. Biological resistance: cancer stem cells. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 125-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. QUIMIOTERAPIA CITOTOXICA; DESREGULACAO; HETEROGENEIDADE TUMOR; TUMOR DE CELULAS ESTAMINAIS; MODELO DE TUMOR DE CELULAS-TRONCO |
| 11358/13381 | US=61 / Câncer Waud WR. Biological resistance: therapeutic resistance in leukemia. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 137-50. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. LEUCEMIA P388; LINHAS TUMORAIS RESISTENTES A DROGAS; RESISTENCIA AS DROGAS; RESISTENCIA TERAPEUTICA |
| 11359/13381 | US=61 / Câncer Arjona AA, Alvarez E. Biological resistance: tumor site implantation and animal model selection in oncology. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 151-9. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. LOCAL DO TUMOR; IMPLANTACAO SUBCUTANEA; TUMORES INTRADERMICOS; ANGIOGENESE; HIPOXIA |
| 11360/13381 | US=61 / Câncer Teicher BA. Biological resistance: in vivo resistance. In: ___. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 161-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. RESISTENCIA A CISPLATINA; RESISTENCIA CICLOFOSFAMIDA; EMT-6 CARCINOMA MAMARIO; RESISTENCIA IN VIVO; FATOR DE CRESCIMENTO TRANSFORMANTE-B |